S100A9 and endothelial dysfunction: In future studies, it is worth to further explore whether S100A9‐RAGE interacts with other signaling molecules using molecular intervention approaches, such as specific inhibitors or RAGE mutant constructs, to comprehensively elucidate the mechanisms underlying endothelial dysfunction.